NEW YORK (MedscapeWire) Dec 27 — Mayo Clinic researchers report the successful use of an antiretroviral drug to combat a brain disease that is responsible for death in as many as 5% of patients with ...
Antiretroviral drug dose adjustment based on age does not appear to be necessary in aging HIV patients, according to a pharmacokinetics study published in the British Journal of Clinical Pharmacology.
Fostemsavir is being developed for use in combination with other antiretroviral agents in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection who are unable to form a ...
Discerning the number of individual factors that may contribute collectively to liver damage is difficult in patients receiving antiretroviral therapy. Several drugs are combined in a given HAART ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today presented the first clinical data in people living with HIV on GS-6207, an investigational, novel, selective, ...
Antiretroviral pharmacokinetics examines how drugs used to treat HIV are absorbed, distributed, metabolised and eliminated in the body. Understanding these processes is critical to ensuring effective ...
Some HAART agents are available as fixed-dose combinations in order to reduce the number of pills the patient must take. The current standard for formulating a HAART regimen recommends the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results